Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide

Daniel Bläser, Simone Maschauer, Torsten Kuwert and Olaf Prante
Journal of Nuclear Medicine August 2006, 47 (8) 1382-1388;
Daniel Bläser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Maschauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torsten Kuwert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olaf Prante
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Immunocytochemical staining of TSHR on FRTL-5 cells. A mouse monoclonal TSHR antibody was used as primary antibody. TSH-treated FRTL-5 cells: (A) Negative control. (B) Primary antibody. TSH-starved FRTL-5: (C) Negative control. (D) Primary antibody.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Uptake of 131I in TSH-treated FRTL-5 thyroid cells. H89 significantly blocked TSH-induced uptake of 131I by 53.8% ± 16.7% (*P < 0.001, n = 8) confirming PKA-mediated increase of radioiodide transport by TSH. Values are mean ± SD of 2 independent experiments, each performed in quadruplicate. NS = not significant (P > 0.05).

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Representative Western blot analysis of GLUT-1 expression in TSH-treated and untreated FRTL-5 rat thyroid cells. Cells were cultured in absence of TSH for 3 d, and TSH (1 mU/mL) was added subsequently. Membrane preparations were obtained as described. Lines A, B, and C show expression of GLUT-1 in membranes of TSH-treated cells (different protein concentrations were loaded on the gel: A, 3.7 μg; B, 7.4 μg; C, 11 μg). Line D shows rat GLUT-1–positive control (PC-Glut-1; FabGennix). Lines E and F visualize GLUT-1 expression of TSH-untreated FRTL-5 cells (E, 3.7 μg; F, 7.4 μg of protein, respectively). The ratio of GLUT-1 signal intensity between TSH-treated (+TSH) and -untreated (−TSH) cells in membrane preparations of equal whole protein mass was determined to be 1.60 ± 0.07 (n = 3).

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Inhibition of (Bu)2cAMP- and TSH-induced increase of 18F-FDG uptake in FRTL-5 cells by the PI3-kinase inhibitor wortmannin. Differences in 18F-FDG uptake values between TSH-activated FRTL-5 cells (+TSH) and TSH-treated cells in the presence of the selective PI3-kinase inhibitor wortmannin (1 μmol/L) were statistically significant (*P < 0.001, n = 20). Values are mean ± SD of 5 independent experiments, each performed in quadruplicate.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Effect of selective PKA inhibitor H89 on (Bu)2cAMP- and TSH-induced 18F-FDG uptake in FRTL-5 cells. H89 did not produce a significant effect on 18F-FDG uptake at concentrations between 0.25 and 25 μmol/L (P > 0.05, n = 4). Values are mean ± SD of 1 typical experiment performed in quadruplicate. Three independent similar experiments yielded qualitatively identical results. c = concentration.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (8)
Journal of Nuclear Medicine
Vol. 47, Issue 8
August 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide
Daniel Bläser, Simone Maschauer, Torsten Kuwert, Olaf Prante
Journal of Nuclear Medicine Aug 2006, 47 (8) 1382-1388;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide
Daniel Bläser, Simone Maschauer, Torsten Kuwert, Olaf Prante
Journal of Nuclear Medicine Aug 2006, 47 (8) 1382-1388;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells
  • Regulation of Uptake of 18F-FDG by a Follicular Human Thyroid Cancer Cell Line with Mutation-Activated K-Ras
  • Google Scholar

More in this TOC Section

  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire